UroGen Submits NDA for UGN-103, an Investigational Treatment of Recurrent LG-IR-NMIBC
CompaniesUroGen Pharma LtdmedacAssetsUGN-103ZUSDURIDiseaseslow-grade intermediate-risk non-muscle invasive bladder cancer
Signals
Every pharma-relevant, de-duplicated event surfaced so far, primary source first. Client-scoped signals are never shown here.
Regarding a Report Concerning Sumitomo Pharma (The Company's Views on “Sumitomo Chemical and Sumitomo Pharmaceutical: Part II - CiRA, Dr. Yamanaka, and the undisclosed history of image duplication concerns”)
CompaniesSumitomo Pharma Co., Ltd.AssetsAMCHEPRY
Sumitomo Pharma America Announces First Patient Receives Treatment in Phase 1/2a Study for its Investigational Therapy DSP-3077 for Retinitis Pigmentosa
CompaniesSumitomo Pharma AmericaAssetsDSP-3077Diseasesretinitis pigmentosa
Structure Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights
CompaniesStructure TherapeuticsAssetsaleniglipronACCG-2671ACCG-3535Diseasesobesitytype 2 diabetes
Skye Bioscience and Redx Pharma Announce Transaction Agreement and $125 Million in Financings
CompaniesSkye BioscienceRedx PharmaAssetsRXC008zelasudil (RXC007)Discoidin Domain Receptor (DDR) inhibitorDiseasesfibrostenotic Crohn's diseaseidiopathic pulmonary fibrosis (IPF)chronic kidney disease
Septerna Highlights Business Progress and Reports Second Quarter 2026 Financial Results
CompaniesSepterna
Revolution Medicines Reports Second Quarter 2026 Financial Results and Update on Corporate Progress
CompaniesRevolution MedicinesAssetsdaraxonrasibzoldonrasibelironrasibRMC-5127RM-055Diseasesmetastatic pancreatic cancernon-small cell lung cancercolorectal cancer
Revolution Medicines and BeOne Medicines Announce Clinical Development and Regional Commercialization Collaboration
CompaniesRevolution MedicinesBeOne MedicinesAssetsdaraxonrasibzoldonrasibelironrasibRMC-5127BGB-58067BG-T187DiseasesRAS-addicted cancers
Protara Therapeutics Announces Second Quarter 2026 Financial Results and Provides a Business Update
CompaniesProtara Therapeutics
Los Angeles Reproductive Urologist Dr. Justin Houman Launches Male Fertility Restoration Program Focused on Natural Conception
CompaniesTower Urology
SOZO® Digital Health Platform Receives FDA Clearance for Sarcopenia Risk Assessment
CompaniesImpediMedAssetsSOZO Digital Health PlatformDiseasessarcopenia
First Person Enters Its Next Phase of Growth Following Early Think Fast™ Momentum
CompaniesFirst PersonQrons, Inc.AssetsThink FastCrystallized Lion's Mane
YogaRenew Debuts Programming to Learn Meditation
CompaniesYogaRenew
Integrity Health Lowers Healthcare Costs by More Than $70 PMPM Using Lightbeam's Population Health Platform
CompaniesIntegrity HealthLightbeam Health SolutionsDiseasesdiabetes
From Caregiver Perspectives to Clinical Trial Design: Advancing Community-Engaged Autism Research
CompaniesCenter for Social DynamicsBehavior Change InstituteDiseasesautism
/C O R R E C T I O N -- Rayence/
CompaniesRayence
National Kidney Registry, National Liver Registry Ensuring Transplant Centers Can Meet OPTN Emergency Policy Deadline
CompaniesNational Kidney RegistryNational Liver Registry
High Profile Cannabis Opens Second Kentucky Dispensary in Wilder, Bringing Medical Access to Northern Kentucky
CompaniesC3 Industries
ADRES Enters Medical Claims Auditing Through Artificial Intelligence, Built with Blend
CompaniesADRESBlend360
/C O R R E C T I O N -- AdventHealth West Florida Division/
CompaniesAdventHealth West Florida Division